Orthologic Corp.
Table of Contents

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported):   January 27, 2004

ORTHOLOGIC CORP.


(Exact name of registrant as specified in its charter)

Delaware


(State or other jurisdiction of incorporation)
     
000-21214   86-0585310

 
(Commission File Number)   (IRS Employer Identification Number)
     
1275 West Washington, Tempe, Arizona   85281

(Address of principal executive offices)   (Zip Code)

Registrant’s telephone number, including area code:      (602) 286-5520

Not Applicable


(Former name or former address, if changed since last report)

 


TABLE OF CONTENTS

Item 7. Exhibits
Item 9. Regulation FD Disclosure
SIGNATURES
INDEX TO EXHIBITS
EXHIBIT 99.1


Table of Contents

Item 7. Exhibits

     (c) Exhibits

         
Exhibit No.   Exhibit Description   Filed Herewith

 
 
99.1   Press release dated January 27, 2004   X

Item 9. Regulation FD Disclosure

     OrthoLogic Corp. announced on January 27, 2004 that the Board of Directors has appointed Michael D. Casey to fill a newly-created vacancy on the OrthoLogic Corp. Board of Directors. Mr. Casey has over 30 years of experience in the pharmaceutical industry. With the addition of Mr. Casey, whose term runs until the next Annual Meeting of Stockholders, the total number of OrthoLogic Corp. directors is now seven.

SIGNATURES

     Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     
Dated:  January 28, 2004   OrthoLogic Corp.
     
    /s/ Thomas Trotter
   
    Thomas Trotter
Chief Executive Officer

 


Table of Contents

INDEX TO EXHIBITS

     
Exhibit No.   Description

 
99.1   Press release, dated January 27, 2004, issued by OrthoLogic Corp.